Lataa...
Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes
Numerous studies suggest that rapamycin treatment promotes insulin resistance, implying that rapamycin could have negative effects on patients with, or at risk for, type 2 diabetes (T2D). New evidence, however, indicates that rapamycin treatment produces some benefits to energy metabolism, even in t...
Tallennettuna:
| Julkaisussa: | Aging (Albany NY) |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5191889/ https://ncbi.nlm.nih.gov/pubmed/27922820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.101117 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|